Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Intermediate <i>Staphylococcus aureus</i> (VISA)

<div>Fluorescence images of (a) VISA mu50, (b) VISA mu50 after treatment with BSA, (c) VISA mu50 after treatment with BSA-AuNCs, and (d) VISA mu3 after treatment with BSA-AuNCs.</div>

Journal of Nanomaterials

fig4

Figure 4

Figure 4: Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) and Vancomycin-Intermediate <i>Staphylococcus aureus</i> (VISA) 

Figure 4 | Antibacterial Activity of BSA-Capped Gold Nanoclusters against Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Intermediate Staphylococcus aureus (VISA) 